Catalyst Wire Dossier Catalyst Wire Dossier

Glubrava

· Takeda Pharma A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glubrava, covering 2022-10-18 to 2022-10-18. Get the full timeline:

Most recent: EMA Withdrawn: Glubrava (metformin hydrochloride;pioglitazone hydrochloride) — Takeda Pharma A/S

See pricing